1 Pitrazepin, 3-(piperazinyl-1)-9H-dibenz(c,f) triazolo(4,5-a)azepin is a piperazine antagonist of GABA in a variety of electrophysiological and in vitro binding studies involving GABA and glycine receptors. In the present study we have investigated the e ects of pitrazepin, and the GABA A antagonist bicuculline, on membrane currents elicited by GABA in Xenopus oocytes injected with rat cerebral cortex mRNA or cDNAs encoding a 1 b 2 or a 1 b 2 g 2S human GABA A receptor subunits. 2 The three types of GABA A receptors expressed were reversibly antagonized by bicuculline and pitrazepin in a concentration-dependent manner. GABA dose-current response curves for the three types of receptors were shifted to the right, in a parallel manner, by increasing concentrations of pitrazepin. 3 Schild analyses gave pA 2 values of 6.42+0.62, n=4, 6.41+1.2, n=5 and 6.21+1.24, n=6, in oocytes expressing rat cerebral cortex, a 1 b 2 or a 1 b 2 g 2S human GABA A receptors respectively (values are given as means+s.e.mean), and the Hill coe cients were all close to unity. All this is consistent with the notion that pitrazepin acts as a competitive antagonist of these GABA A receptors; and that their antagonism by pitrazepin is not strongly dependent on the subunit composition of the receptors here studied. 4 Since pitrazepin has been reported to act also at the benzodiazepine binding site, we studied the e ect of the benzodiazepine antagonist Ro 15-1788 (¯umazenil) on the inhibition of a 1 b 2 g 2S receptors by pitrazepin. Co-application of Ro 15-1788 did not alter the inhibiting e ect of pitrazepin. Moreover, pitrazepin did not antagonize the potentiation of GABA-currents by¯unitrazepam. All this suggests that pitrazepin does not a ect the GABA receptor-chloride channel by interacting with the benzodiazepine receptor site.